Evaluation of microRNA-205 expression as a potential triage marker for patients with low-grade squamous intraepithelial lesions
Open Access
- 24 March 2017
- journal article
- research article
- Published by Spandidos Publications in Oncology Letters
- Vol. 13 (5) , 3586-3598
Abstract
High-risk human papillomavirus (HPV) testing is a recommended triage approach for females with atypical squamous cells of undetermined significance (ASCUS), but due to its poor specificity this approach is not recommended for patients with low‑grade squamous intraepithelial lesions (LSIL). The objective of the current study was to determine microRNA (miR)‑205 expression levels in liquid‑based cytology (LBC) samples, and evaluate their ability to predict cervical intraepithelial neoplasia grade 2/3 or worse (CIN2/3+) in females with minor cytological abnormalities. LBC samples were obtained from patients attending the Swedish Cervical Cancer Screening Program. The Mann‑Whitney U test, one‑way analysis of variance, Kruskal‑Wallis test, Spearman rank order correlation analysis, and Pearson's χ2 test were used to assess the results. Accuracy analyses indicated that high miR‑205 expression had a significantly higher specificity to high‑risk HPV testing, and a sensitivity similar to that of high‑risk HPV testing to predict CIN2+ and CIN3+ in women with LSIL, but not those with high‑grade squamous intraepithelial lesions. Although further research is required for females with LSIL, miR‑205 expression in LBC samples may be a novel triage marker for, or a beneficial supplement to high‑risk‑HPV testing in these patients.Keywords
This publication has 45 references indexed in Scilit:
- Circulating miRNA-20a and miRNA-203 for Screening Lymph Node Metastasis in Early Stage Cervical CancerGenetic Testing and Molecular Biomarkers, 2013
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controlsBMC Biology, 2010
- MicroRNAs in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- Human papillomavirus ‘reflex’ testing as a screening method in cases of minor cytological abnormalitiesBritish Journal of Cancer, 2008
- Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cellsOncogene, 2007
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007
- Overview of the European and North American studies on HPV testing in primary cervical cancer screeningInternational Journal of Cancer, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001